Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Otago researchers in major new study of TB and diabetes

Otago researchers in major new study of TB and diabetes epidemics

University of Otago expertise is set to play a key role in European Commission (EC) funded research into links between infectious and non-communicable diseases – in this case tuberculosis (TB) and type 2 diabetes.

The EC has earmarked €6 billion for health research under its Seventh Framework Programme (FP7) for the funding of research and technological development, of which €6 million (NZ$9.5 million) has been awarded to the new project.

Co-Director of the University’s Centre for International Health, Professor Philip Hill, says the initial call was for projects that combine one of the three major poverty-related diseases – HIV/AIDS, malaria and tuberculosis – with the major non-infectious diseases including rheumatic or cardiovascular disease, cancer and diabetes.

“This year nine million people will be diagnosed with TB and up to 1.4 million will die from it. We also know that just under 400 million people live with diabetes and around 10 - 20% of new cases of TB are also diabetic, which is a much higher percentage than you would expect by chance,” Professor Hill says.

“There are more TB cases with diabetes than there are with HIV and while diabetes doesn't have as dramatic an effect on TB as HIV does, it is clearly a significant player - presumably through an effect on the immune system. The fact that the number of people worldwide with diabetes is increasing at an alarming rate will have an effect on global TB control.”

Professor Hill, who has an extensive record in TB research in developing countries, will be part of a multi-disciplinary consortium linking field sites in four TB-endemic countries that are experiencing a rapid growth of type 2 diabetes – namely Romania, Peru, South Africa and Indonesia.

The €6 million (NZ$9.5 million) project, which will be known as TANDEM (Tuberculosis and Diabetes ­Mellitus), will see Otago researchers collaborating with leading laboratories in Germany, UK, Netherlands and Romania. The project’s official start date is 1 February 2013.

The consortium’s aim is to increase knowledge of the causative links between the two diseases and by doing that develop better prevention, treatment and management of them so that mortality rates can be reduced and quality of life improved.

Professor Hill, who was part of the team that designed the study, says the consortium wants to test the hypothesis that screening and management can be greatly improved and simplified with a major impact on the control of TB and diabetes co-morbidity.

“We will explore how best to screen people with TB for diabetes and we will also be able to give an indication, across continents, of the actual proportion of TB patients who also have diabetes, and their basic characteristics.”

TANDEM will also examine the best medications and treatments for TB in this group of patients and explore what their long-term requirements are in terms of diabetes treatment once they have finished their TB treatment.

The study will also look at the effect of glucose control on TB treatment outcome and also look for immune system abnormalities and genetic variations common to both diseases.

Professor Hill says one of the great plusses of a multi-site study like this is the greater statistical power it provides. The researchers will end up with 1500 - 2000 TB cases to study and of those, around 350-400 will also have diabetes.

Otago will be particularly involved in the study based in Indonesia, as part of their formal collaboration with Padjadjaran University, and that study alone will provide about 400 TB cases.

“It is a great privilege to be involved in a European Union study,” says Professor Hill.

“We couldn’t apply on our own; we needed to be part of a consortium and offer something that is not easily available within the EU. Our previous field studies in TB and our growing collaboration with Padjadjaran University provides that.”

ends

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Post-Post: Brian Roche To Step Down As NZ Post CEO

Brian Roche will step down as chief executive of New Zealand Post in April 2017, having led the state-owned postal service's drive to adjust to shrinking mail volumes with a combination of cost cuts, asset sales, modernisation and expansion of new businesses. More>>

ALSO:

Company Results: Air NZ Rides The Tourism Boom With Record Full-Year Earnings

Air New Zealand has ridden the tourism boom and staved off increased competition to deliver the best full-year earnings in its 76-year history. More>>

ALSO:

New PGP: Sheep Milk Industry Gets $12.6M Crown Funding

The Sheep - Horizon Three programme aims to develop "a market driven, end-to-end value chain generating annual revenues of between $200 million and $700 million by 2030," according to a joint statement. More>>

ALSO:

Half Full: Fonterra Raises Forecast Milk Price

Fonterra Co-operative Group Limited today increased its 2016/17 forecast Farmgate Milk Price by 50 cents to $4.75 per kgMS. When combined with the forecast earnings per share range for the 2017 financial year of 50 to 60 cents, the total payout available to farmers in the current season is forecast to be $5.25 to $5.35 before retentions. More>>

ALSO:

Keep Digging: Seabed Ironsands Miner TransTasman Tries Again

The first company to attempt to gain a resource consent to mine ironsands from the ocean floor in New Zealand's Exclusive Economic Zone has lodged a new application containing fresh scientific and other evidence it hopes will persuade regulators after their initial application was turned down in 2014. More>>

Wool Pulled: Duvets Sold As ‘Premium Alpaca’ Mostly Sheep’s Wool

Rotorua business Budge Collection Limited (Budge) and sole director, Sun Dong Kim, were convicted and fined a total of $71,250 in Auckland District Court after each pleading guilty to four charges of misrepresenting how much alpaca fibre was in their duvets. More>>

Get More From Scoop

 
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news